CNS Disorders  >>  carbidopa/levodopa  >>  Phase N/A
Welcome,         Profile    Billing    Logout  

12 Trials

Remove FilterRemove Filter

Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
carbidopa/levodopa / Generic mfg.
ACTRN12624001010583: Does levodopa/carbidopa, a common Parkinson's Disease drug, affect stomach emptying, blood pressure and heart rate?

Recruiting
N/A
20
 
Professor Karen Jones, The University of Adelaide, Royal Adelaide Hospital Clinical Project Grant
Parkinson's disease, Postprandial hypotension, Delayed gastric emptying
 
 
NCT00129181 / 2004-001485-41: Study of the Effects of Dopaminergic Medications on Dopamine Transporter Density in Subjects With Parkinson's Disease

Completed
N/A
30
Europe
cabergoline, carbidopa/levodopa, DATscan and SPECT imaging
Institute for Neurodegenerative Disorders, Pfizer, GE Healthcare
Parkinson Disease, Parkinsonian Syndrome
12/06
01/07
NCT00460954: A Multiple-Dose Study of Sinemet® CR (Carbidopa/Levodopa) in Healthy Subjects

Completed
N/A
20
Canada
Sinemet® controlled release (Carbidopa/levodopa)
Bristol-Myers Squibb
Parkinson's Disease
 
08/07
NCT00624741: Compassionate Use Study of Pergolide in Patients With Parkinson's Disease

No Longer Available
N/A
US
Pergolide, Permax
Bausch Health Americas, Inc.
Parkinson Disease
 
 
NCT01528592: PharmacoMRI of Parkinson Disease

Completed
N/A
18
US
Carbidopa-Levodopa
Northwestern University
Parkinson's Disease
07/12
07/12
NORAPARK, NCT02578849: Common Noradrenergic Mechanisms in Parkinson´s Disease and L-DOPA Induced Dyskinesia

Unknown status
N/A
45
Europe
L-DOPA, Sinemet
Aarhus University Hospital, University of Copenhagen
Parkinson´s Disease
01/16
01/16
NCT01754129: Global REsponsE During iNFusIon of a gEl With LevoDopa/Carbidopa

Completed
N/A
148
NA
AbbVie (prior sponsor, Abbott)
Parkinson's Disease
05/16
05/16
NeuroInfiam, NCT03918616: P2X7 Receptor, Inflammation and Neurodegenerative Diseases

Completed
N/A
50
Europe
Memantine, Dopamine receptor-agonists, Memantine: Ebixa. Dopamine receptor-agonists: Sinemet, Sirio.
University of Pisa
Neuro-Degenerative Disease
12/18
03/19
PD QOL, NCT04590612: Improving Quality of Life in Early Parkinson's Disease

Not yet recruiting
N/A
30
NA
Carbidopa-Levodopa 25 Mg-100 Mg Oral Tablet, L-DOPA, l-3,4-dihydroxyphenylalanine, Sinemet, Citalopram, Celexa
Western University, Canada
Parkinson Disease, Depression
01/22
01/22
SmIle, NCT06003608: Observational Small Intestine and Blood Fingerprint () Study in Parkinson's Disease

Recruiting
N/A
100
Canada
Fluid biopsy capsule, Levodopa-Carbidopa Immediate Release
Nimble Science Ltd., MRM Health N.V.
Parkinson Disease
08/24
09/24
NCT02994719: Gait Analysis in Neurological Disease

Recruiting
N/A
120
US
Anti-Parkinson medication, Carbidopa/levodopa, pramipexole, ropinirole, amantadine, tolcapone, entacapone, Deep Brain Stimulation
Beth Israel Deaconess Medical Center
Parkinson's Disease, Parkinsonian Disorders, Atypical Parkinson Disease, Progressive Supranuclear Palsy, Multiple System Atrophy, Corticobasal Degeneration, Gait, Frontal, Huntington Disease
06/25
06/25
NCT04821830: Vigor and the LDR in Parkinson Disease

Recruiting
N/A
40
US
carbidopa/levodopa, as prescribed by treating physician, Parcopa, Sinemet
University of Michigan, National Institute of Neurological Disorders and Stroke (NINDS)
Parkinson Disease
02/25
02/25

Download Options